Loading clinical trials...
Loading clinical trials...
Canadian Fabry Disease Initiative National Registry: Outcomes of Rare Disease Therapeutics and Cardiovascular Risk Factor Modification
Conditions
Interventions
No intervention
Locations
5
Canada
Alberta Children's Hospital
Calgary, Alberta, Canada
Vancouver General Hospital Adult Metabolic Diseases Clinic
Vancouver, British Columbia, Canada
Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, Canada
Toronto Western Hospital
Toronto, Ontario, Canada
University of Montreal, Department of Medicine
Montreal, Quebec, Canada
Start Date
January 1, 2007
Primary Completion Date
October 1, 2029
Completion Date
October 1, 2029
Last Updated
February 15, 2024
NCT06941025
NCT07382128
NCT05923788
NCT05473637
NCT07277361
NCT04252066
Lead Sponsor
Canadian Fabry Research Consortium
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions